STEARIC HYDRAZIDE
STEARIC HYDRAZIDE is a cosmetic ingredient classified as Not Reported. Also known as CAS 4130-54-5. It is regulated in 1 market including South Korea.
Also Known As
- CAS Number
- 4130-54-5, 54-85-3
Market Overview — 29 Markets
Detailed Regulations
EuropeNo restrictions
No specific restrictions for STEARIC HYDRAZIDE in European Union, United Kingdom.
AmericasNo restrictions
No specific restrictions for STEARIC HYDRAZIDE in United States, California, Maryland, Washington, Canada, Brazil.
East Asia & Oceania1 regulation
- Chemical name
- Stearic Hydrazide
Source: MFDS Korea Cosmetics Regulation
ASEANNo restrictions
No specific restrictions for STEARIC HYDRAZIDE in Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines.
GCCNo restrictions
No specific restrictions for STEARIC HYDRAZIDE in UAE, Saudi Arabia, Qatar, Oman, Kuwait, Bahrain.
EAEUNo restrictions
No specific restrictions for STEARIC HYDRAZIDE in Russia, Belarus, Kazakhstan, Armenia, Kyrgyzstan.
Frequently Asked Questions
Is STEARIC HYDRAZIDE banned in any country?
Yes, STEARIC HYDRAZIDE is banned in South Korea. Always check current regulations before formulating products for these markets.
What are the restrictions on STEARIC HYDRAZIDE in cosmetics?
STEARIC HYDRAZIDE is banned in South Korea and has no specific restrictions in other tracked markets.
Can I use STEARIC HYDRAZIDE in cosmetics?
STEARIC HYDRAZIDE is regulated in 1 market. It is banned in South Korea. Use Formpli's free screening tool to check your full ingredient list against all 26 markets at once.
Screen STEARIC HYDRAZIDE with your full formula
Paste your entire ingredient list and get a compliance report across 26 markets — free, no signup.
Check Ingredients FreeThis information is for reference only and does not constitute legal or regulatory advice. Regulations change — always verify with official sources and consult a regulatory specialist before exporting cosmetic products. Data sourced from EU COSING, US FDA, Health Canada, MHLW Japan, MFDS Korea, ASEAN ACD, GCC SFDA, TGA Australia, ANVISA Brazil, EAEU TR CU, and Taiwan TFDA.